Related Experiment Video
Updated: Feb 22, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Onchocerca volvulus: The Road from Basic Biology to a Vaccine
Sara Lustigman1, Benjamin L Makepeace2, Thomas R Klei3
1Laboratory of Molecular Parasitology, Lindsley F Kimball Research Institute, New York Blood Center, New York, NY, USA.
Abstract:
Human onchocerciasis - commonly known as river blindness - is one of the most devastating yet neglected tropical diseases, leaving many millions in sub-Saharan Africa blind and/or with chronic disabilities. Attempts to eliminate onchocerciasis, primarily through the mass drug administration of ivermectin, remains challenging and has been heightened by the recent news that drug-resistant parasites are developing in some populations after years of drug treatment. Needed, and needed now, in the fight to eliminate onchocerciasis are new tools, such as preventive and therapeutic vaccines. This review summarizes the progress made to advance the onchocerciasis vaccine from the research laboratory into the clinic.
Insights
New vaccines are urgently needed to combat river blindness (onchocerciasis) due to ivermectin resistance. This review details progress in developing onchocerciasis vaccines for clinical use.
Area of Science:
- Neglected tropical diseases
- Parasitic diseases
- Vaccinology
Background:
- Human onchocerciasis, or river blindness, causes significant disability in sub-Saharan Africa.
- Mass drug administration with ivermectin is the primary elimination strategy but faces challenges.
- Emerging drug resistance in parasites necessitates novel intervention tools.
Purpose of the Study:
- To review the progress of onchocerciasis vaccine development.
- To highlight advancements from research toward clinical application.
Main Methods:
- Literature review of onchocerciasis vaccine research.
- Analysis of progress in preclinical and clinical development stages.
Main Results:
- Significant research efforts are underway to develop onchocerciasis vaccines.
- Progress has been made in advancing vaccine candidates from laboratory research.
Conclusions:
- Preventive and therapeutic vaccines are crucial new tools for onchocerciasis elimination.
- Continued research and development are vital to bring effective vaccines to the clinic.
Related Concept Videos
Preclinical Development: Overview
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Retrovirus Life Cycles
Vaccinations
Microorganisms in Medicine and Therapeutics

